Autoreactivity in patients with respiratory sarcoidosis.

U. Zinchenko (St. Petersburg, Russian Federation), A. Starshinova (St. Petersburg, Russian Federation), N. Denisova (St. Petersburg, Russian Federation), S. Lapin (St. Petersburg, Russian Federation), A. Mazing (St. Petersburg, Russian Federation), E. Surkova (St. Petersburg, Russian Federation), P. Yablonskii (St. Petersburg, Russian Federation)

Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes
Session: Sarcoidosis: from basic research to patient outcomes
Session type: Poster Discussion
Number: 5212
Disease area: Interstitial lung diseases

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
U. Zinchenko (St. Petersburg, Russian Federation), A. Starshinova (St. Petersburg, Russian Federation), N. Denisova (St. Petersburg, Russian Federation), S. Lapin (St. Petersburg, Russian Federation), A. Mazing (St. Petersburg, Russian Federation), E. Surkova (St. Petersburg, Russian Federation), P. Yablonskii (St. Petersburg, Russian Federation). Autoreactivity in patients with respiratory sarcoidosis.. 5212

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Localization of respiratory viral antigens in patients with exacerbations of non allergic late-onset asthma and chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 24: Suppl. 48, 411s
Year: 2004

Evolution and prognosis of patients with Asthma or COPD hospitalized by COVID-19 infection. Diferences between them and the patients without airway pathology.
Source: Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects
Year: 2021


The prevelance of respiratory infections in vaccined patients with chronic obstructive pulmonary disease
Source: Annual Congress 2011 - Quality of diagnosis and assessment in primary care
Year: 2011

Respiratory infections in patients with idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2009 - Idiopathic pulmonary fibrosis: concepts and mechanisms
Year: 2009

Respiratory viral infections in patients with exacerbation of chronic obstructive pulmonary disease and asthma in Korea
Source: Eur Respir J 2005; 26: Suppl. 49, 285s
Year: 2005

IgG immunoglobulin levels and the frequency of respiratory infections in patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2002; 20: Suppl. 38, 543s
Year: 2002

Broncho-obstructive syndrome in patients with granulomatous pulmonary diseases.
Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage
Year: 2019

Autopsy-proven pulmonary determinants in patients with acute respiratory failure
Source: Annual Congress 2010 - Intensive care unit outcome
Year: 2010

Home-NIV in patients with COPD after acute respiratory failure
Source: Annual Congress 2008 - Noninvasive mechanical ventilation in the acute setting
Year: 2008


Respiratory viral infections in Iranian patients with exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2010 - Bronchiectasis and respiratory infections caused by Pseudomonas
Year: 2010

Pulmonary function in patients recovering from severe acute respiratory syndrome (SARS)
Source: Eur Respir J 2004; 24: Suppl. 48, 239s
Year: 2004

Evaluation of incidental exacerbation of interstitial pneumonia in patients with non-respiratory diseases
Source: International Congress 2017 – Rare diseases
Year: 2017

Clinical features of invasive pulmonary aspergillosis in critical ill patients with chronic respiratory disease
Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi
Year: 2008

Respiratory comorbidities and risk of mortality in hospitalized patients with idiopathic pulmonary fibrosis.
Source: International Congress 2017 – ILDs: clinical aspects
Year: 2017

The treatment of acute respiratory viral infections in a patients with a chronic obstructive pulmonary disease
Source: Annual Congress 2012 - Fungal, viral and other infections
Year: 2012


Clinical relevance of respiratory pathogens in patients hospitalised with acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Interesting cases of respiratory infections
Year: 2013


Correlation between respiratory muscles function, systemic inflammation and dyspnoea in patients with severe COPD
Source: Annual Congress 2009 - Respiratory mechanics, tissue and cell dysfunction in pulmonary disease
Year: 2009


Association of neoepitopes with disease severity and respiratory hospitalization in patients with IPF
Source: Virtual Congress 2020 – Promising biomarkers for idiopathic interstitial pneumonia
Year: 2020




Interferon inducer in treatment of acute respiratory viral infections in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options
Year: 2014

Influence of bronchiectasis in patients hospitalized due to acute exacerbation of COPD.
Source: International Congress 2017 – Towards personalised medicine in COPD: biological and clinical phenotypes
Year: 2017